2020
DOI: 10.1093/intimm/dxaa071
|View full text |Cite
|
Sign up to set email alerts
|

Psoriasis-like skin disorder in transgenic mice expressing a RIG-I Singleton–Merten syndrome variant

Abstract: Mutations in DDX58, which encodes the cytoplasmic RNA sensor RIG-I, were recently identified in the rare autoimmune disease Singleton–Merten syndrome (SMS). We report the spontaneous development of psoriasis-like skin lesions as an SMS-like symptom in transgenic mice harboring one of the RIG-I SMS variants, E373A. Histological analysis revealed typical characteristics of psoriasis, including the abnormal proliferation and differentiation of keratinocytes leading to epidermal hyperplasia, and infiltrates consis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…Specifically, Janus kinase (JAK) inhibitors such as baracitinib hold significant promise in reducing the neurological features of Aicardi–Goutieres, though randomized-controlled trials are needed to substantiate these effects [ 160 ]. While these therapies have not been systematically attempted for SGMRT, there is evidence from animal models that they may be also effective for this condition [ 161 ]. It is unclear whether these immunomodulatory therapies can be useful for the management of glaucoma associated with these conditions and that remains a topic of investigation.…”
Section: Syndromesmentioning
confidence: 99%
“…Specifically, Janus kinase (JAK) inhibitors such as baracitinib hold significant promise in reducing the neurological features of Aicardi–Goutieres, though randomized-controlled trials are needed to substantiate these effects [ 160 ]. While these therapies have not been systematically attempted for SGMRT, there is evidence from animal models that they may be also effective for this condition [ 161 ]. It is unclear whether these immunomodulatory therapies can be useful for the management of glaucoma associated with these conditions and that remains a topic of investigation.…”
Section: Syndromesmentioning
confidence: 99%
“…In contrast, RIG-I overexpression in the respiratory system shows protection against influenza infection [ 45 ]. Transgenic mice carrying a bacterial artificial chromosome introducing the human DDX58 p.Glu373Ala variant showed psoriasis-like skin lesions with IL-23/IL-17 immune axis activation and systemic inflammation [ 46 ]. Ocular features of gain or loss-of-function DDX58 mouse strains have not been examined to date.…”
Section: Genetic Disorders and Features Of Innate Immune Pathway Componentsmentioning
confidence: 99%